<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 08 Nov 2009 13:36:02 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Estimating Future Dividend Growth</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3615792</guid>
      <description><![CDATA[Estimating future dividend growth is difficult if not impossible. Companies which might have had a long history of consistent double digit increases might stop raising dividends and might even cut them.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3615792>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 23:21:36 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EMR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PEP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">USB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3615792</link>
    </item>
    <item>
      <title>Biostar Raises $3.6 Million</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</guid>
      <description><![CDATA[Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614366>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 17:26:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BSPM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</link>
    </item>
    <item>
      <title>Bulls Back On Track?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</guid>
      <description><![CDATA[Good morning. With chants of &quot;Dow 10K… Dow 10K&quot; once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614255>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 16:21:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</link>
    </item>
    <item>
      <title>Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</guid>
      <description><![CDATA[Ford's 2,215 page 2007 master contract with the UAW 
1941 UAW-Ford contract<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614051>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 13:52:50 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</link>
    </item>
    <item>
      <title>Options Intellignece Report : Options Activity for XRT, CVS, STT, PFE, FSYS &amp; AEO</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611839</guid>
      <description><![CDATA[Today's tickers: XRT, CVS, STT, PFE, CVS, FSYS &amp; AEO<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611839>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 19:12:19 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AEO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FSYS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XRT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611839</link>
    </item>
    <item>
      <title>Your Kind of Day?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</guid>
      <description><![CDATA[As a rule, I try not to read too terribly much into a &quot;Fed Day&quot; as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on &quot;Fed Days.&quot; But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611831>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 19:06:48 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TGT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</link>
    </item>
    <item>
      <title>The Dollar-Proof Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</guid>
      <description><![CDATA[Don't put off this important piece of the financial-planning process.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611744>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 17:31:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CEW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IEO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MON</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STPZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VEU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VSS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VTI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WIP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</link>
    </item>
    <item>
      <title>ADP Sees 203,000 Jobs Lost</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3606268</guid>
      <description><![CDATA[This morning, Automatic Data Processing (ADP), the biggest payroll processing firm, estimated that the economy lost 203,000 private sector jobs in October. That was more than the consensus estimate of 190,000 jobs lost. However, the September job loss numbers were revised to a loss of just 227,000 from the original read of 254,000. Thus the losses are coming from a higher base level, and if the revisions are included, this report was in line with consensus or perhaps a bit better.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3606268>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 17:07:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3606268</link>
    </item>
    <item>
      <title>Dividend Stocks: A Disciplined Approach</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3605936</guid>
      <description><![CDATA[Those that have read this space for any period of time are well aware of my enthusiasm for using dividend growth stocks as a vehicle for building long-term wealth and income.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3605936>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 14:27:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AINV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">APOL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CMO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3605936</link>
    </item>
    <item>
      <title>Pre-Market: Stocks Headed Higher Ahead Of Fed Release</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3605775</guid>
      <description><![CDATA[Stock futures have put up solid gains throughout pre-market trading and modestly extended their move in the wake of the ADP private sector employment report. It showed a slower rate of job losses and lifts some hope for a similar result in Friday's Labor Dept. release.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3605775>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 13:15:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3605775</link>
    </item>
    <item>
      <title>Inspire reports $8.5 million 3Q loss</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614393</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 6--DURHAM -- Inspire Pharmaceuticals Inc. on Thursday reported a loss of $8.5 million for the third quarter, mostly owing to an increase in expenses even as revenues for the company's lead products rose. &lt;/li&gt;&lt;li&gt;Operating expenses for the third quarter totaled $33.1 million, up from $29 million a year ago, primarily because of higher research and development expenses, including a $3.3 million milestone payment to Yamasa Corp. for a technology agreement to enable a two-supplier strategy for denufosol, the company's candidate for treating cystic fibrosis. &lt;/li&gt;&lt;li&gt;Revenue from Azasite, the company's candidate for treating pinkeye, was $9.0 million, nearly double the $4.7 million from the third quarter of 2008.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614393>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 17:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614393</link>
    </item>
    <item>
      <title>Productivity gains may be bad news for job seekers</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3610751</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;WASHINGTON - Companies across the economy are finding ways to do more with fewer workers, dimming hopes that hiring will take off anytime soon.&lt;/li&gt;&lt;li&gt;The result is that productivity - output per hour of work - jumped at the fastest pace in six years.&lt;/li&gt;&lt;li&gt;Productivity rose at an annual rate of 9.5 percent in the July-September quarter, the Labor Department said Thursday.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3610751>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 17:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MSFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">S</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3610751</link>
    </item>
    <item>
      <title>Productivity gains may be bad news for job seekers</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3610382</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;WASHINGTON - Companies across the economy are finding ways to do more with fewer workers, dimming hopes that hiring will take off anytime soon.&lt;/li&gt;&lt;li&gt;The result is that productivity - output per hour of work - jumped at the fastest pace in six years.&lt;/li&gt;&lt;li&gt;Productivity rose at an annual rate of 9.5 percent in the July-September quarter, the Labor Department said Thursday.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3610382>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 15:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MSFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">S</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3610382</link>
    </item>
    <item>
      <title>Spinal Modulation secures $27.4 million in series C financing</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3610241</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Spinal Modulation, a US-based medical device company, has completed its $27.4 million series C financing.&lt;/li&gt;&lt;li&gt;DFJ/InCube Ventures and Raffles Venture Partners are additional new investors. &lt;/li&gt;&lt;li&gt;David Wood, president and CEO of Spinal Modulation, said: &quot;As we begin to better understand the mechanisms behind the disease, treatment options will advance and patients will have more alternatives.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3610241>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 14:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3610241</link>
    </item>
    <item>
      <title>New jobless claims drop to 512K, lowest since Jan.</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3610145</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;WASHINGTON - The number of newly laid-off workers filing claims for unemployment benefits last week fell to the lowest level in 10 months, evidence that job cuts are easing as the economy slowly heals.&lt;/li&gt;&lt;li&gt;Still, companies are reluctant to hire and economists expect the unemployment rate will tick up to 9.9 percent when October's figure is reported Friday. &lt;/li&gt;&lt;li&gt;The Labor Department said Thursday that first-time claims for jobless benefits fell by 20,000 to a seasonally adjusted 512,000.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3610145>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 13:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3610145</link>
    </item>
    <item>
      <title>Ahead of the Bell: Jobless claims</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3609989</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;WASHINGTON - The number of newly laid-off workers seeking unemployment benefits likely dropped slightly last week, evidence that the job market is slowly improving as the economy recovers from the worst recession since the 1930s.&lt;/li&gt;&lt;li&gt;That would continue a downward trend that has seen claims drop in six of the past eight weeks.&lt;/li&gt;&lt;li&gt;The unemployment benefit rolls, meanwhile, are expected to drop by about 50,000 to 5.7 million for the week ending Oct. 24.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3609989>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 11:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MSFT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3609989</link>
    </item>
    <item>
      <title>ISM's service sector index grows again in October</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3607848</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - The U.S. service sector grew for a second straight month in October, but at a slower pace than in September, as a broad economic recovery creeps along.&lt;/li&gt;&lt;li&gt;The Institute for Supply Management said Wednesday that its service index dipped to 50.6 last month from 50.9. &lt;/li&gt;&lt;li&gt;But new orders, an augur of future activity, rose to 55.6, from 54.2 in September.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3607848>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 20:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3607848</link>
    </item>
    <item>
      <title>ISM's service sector index grows again in October</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3606273</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - The U.S. service sector grew for a second straight month in October, but at a slower pace than in September, as a broad economic recovery creeps along.&lt;/li&gt;&lt;li&gt;But new orders, an augur of future activity, rose to 55.6, from 54.2 in September. &lt;/li&gt;&lt;li&gt;In the ISM's survey, nine industries said their businesses grew last month, with real estate, construction, corporate management and support services showing the biggest gains.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3606273>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 17:11:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3606273</link>
    </item>
    <item>
      <title>Chicago Tribune Gail MarksJarvis column: Bleak outlook for jobs</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3605257</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 4--Although investors have been pocketing several tidbits of good news about the economy since March, jobs numbers have not been among them. &lt;/li&gt;&lt;li&gt;Johnson and Johnson announced thousands of job cuts Tuesday, and economists are expecting the unemployment rate in October to increase to 9.9 percent. &lt;/li&gt;&lt;li&gt;Even if unemployment peaks next year, healing is expected to take years.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3605257>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 09:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3605257</link>
    </item>
    <item>
      <title>Burlington Northern, Ford, UBS are big movers</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3604303</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - The following stocks were among those that moved substantially or traded heavily Tuesday on the New York Stock Exchange:&lt;/li&gt;&lt;li&gt;Berkshire Hathaway Inc. agreed to buy the nation's second-largest railroad and biggest hauler of food products for $34 billion.&lt;/li&gt;&lt;li&gt;The Swiss bank posted a third-quarter net loss of 564 million Swiss francs ($542 million), blaming accounting charges.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3604303>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 23:11:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BDK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BRK.A</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSIQ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DDRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PEET</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RCL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SWK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3604303</link>
    </item>
    <item>
      <title>Cytokinetics Announces Addition to Board of Directors</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3613860</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that Pat Gage has been appointed to the company's Board of Directors.&lt;/li&gt;&lt;li&gt;From 1998 to 2002, Dr. Gage was President of Wyeth Research and subsequently also Senior Vice President, Science and Technology.  &lt;/li&gt;&lt;li&gt;&quot;We are pleased to welcome Pat to our Board of Directors at this important next stage of Cytokinetics' evolution,&quot; stated Robert I. Blum, Cytokinetics' President and Chief Executive Officer.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3613860>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3613860</link>
    </item>
    <item>
      <title>Achillion Reports Third Quarter Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3613869</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW HAVEN, Conn., Nov. 6, 2009 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three and nine months ended September 30, 2009. &lt;/li&gt;&lt;li&gt;For the third quarter of 2009, the Company reported a net loss of $6.4 million, compared with a net loss of $6.7 million for the same period last year. &lt;/li&gt;&lt;li&gt;Cash, cash equivalents and marketable securities as of September 30, 2009 were $15.3 million.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3613869>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACHN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3613869</link>
    </item>
    <item>
      <title>NPS Pharmaceuticals Reports Third Quarter Results and Improved Cash Burn Guidance</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3607813</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company   focused on developing therapeutics for rare gastrointestinal and   endocrine disorders, today reported third quarter 2009 financial results   and improved cash burn guidance.&lt;/li&gt;&lt;li&gt;The company's net loss was $7.8 million or $0.16 per   diluted share for the third quarter of 2009 versus a net loss of $11.4   million or $0.24 per diluted share for the third quarter of 2008. &lt;/li&gt;&lt;li&gt;The   net loss for the third quarter of 2008 included a non-operating charge   of $10.8 million related to a decline in the estimated fair value of the   company's auction-rate securities (ARS) investments.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3607813>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 20:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NPSP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3607813</link>
    </item>
    <item>
      <title>Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3605710</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Celldex Therapeutics, Inc. (NASDAQ: CLDX) today reported financial   results for the third quarter and nine-month period ended September 30,   2009. &lt;/li&gt;&lt;li&gt;For the nine months   ended September 30, 2009, Celldex reported a net loss of $23.6 million,   or $1.49 per share, compared to a net loss of $40.0 million, or $2.92   per share, for the nine months ended September 30, 2008. &lt;/li&gt;&lt;li&gt;At September 30, 2009, CuraGen Corporation, which Celldex acquired on   October 1, 2009, had cash and investments of $70.3 million and 4%   convertible subordinated debt of $12.5 million, due in February 2011.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3605710>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CLDX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3605710</link>
    </item>
    <item>
      <title>Impax Laboratories Confirms Patent Challenge Relating to TRICOR&amp;#174; 48mg and 145mg Tablets</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3593490</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Impax Laboratories, Inc. (NASDAQ:IPXL) today confirms that   it has initiated a challenge of the patents listed by Abbott   Laboratories in connection with its TRICOR&amp;#174; (fenofibrate) tablets, 48 mg   and 145 mg.&lt;/li&gt;&lt;li&gt;Impax filed its Abbreviated New Drug Application (&quot;ANDA&quot;) containing a   Paragraph IV certification for a generic version of TRICOR&amp;#174; with the   U.S. Food &amp; Drug Administration (&quot;FDA&quot;). &lt;/li&gt;&lt;li&gt;Following receipt of the notice   from the FDA that Impax's ANDA had been accepted for filing, Impax   notified the New Drug Application holder and patent owners of its   Paragraph IV certification.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3593490>[More...]</a>]]></description>
      <pubDate>Fri, 30 Oct 2009 14:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IPXL</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3593490</link>
    </item>
    <item>
      <title>Phase Forward Reports Third Quarter 2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3591497</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data   management solutions for clinical trials and drug safety, today   announced its financial results for the third quarter of 2009.&lt;/li&gt;&lt;li&gt;Within total   revenues, electronic data capture (EDC) license, application hosting and   other related revenues were $38.5 million, representing 71% of third   quarter total non-GAAP revenues and an increase of 18% from $32.7   million in the prior year period.&lt;/li&gt;&lt;li&gt;Weiler added, &quot;During the third quarter, a pharmaceutical company in the   top 40 in sales selected Phase Forward's InForm EDC solution for a   multi-year, multi-million dollar commitment, while a leading provider of   information technology, consulting, and business process outsourcing   services selected InForm as part of their outsourcing services to a top   10 pharma.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3591497>[More...]</a>]]></description>
      <pubDate>Thu, 29 Oct 2009 20:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFWD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3591497</link>
    </item>
    <item>
      <title>DJO Incorporated Announces Financial Results for Third Quarter 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3586338</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;DJO Incorporated (&quot;DJO&quot; or the &quot;Company&quot;), a global provider of medical   device solutions for musculoskeletal health, vascular health and pain   management, today announced financial results for its operating   subsidiary, DJO Finance LLC (&quot;DJOFL&quot;), for the third quarter of 2009,   ended September 26, 2009. &lt;/li&gt;&lt;li&gt;Following completion of the DJO Merger, ReAble   changed its name to DJO Incorporated. &lt;/li&gt;&lt;li&gt;Results of   the ETS business for periods prior to the date of sale, have been   presented as discontinued operations.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3586338>[More...]</a>]]></description>
      <pubDate>Wed, 28 Oct 2009 11:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3586338</link>
    </item>
    <item>
      <title>PicksThatMove.Com Announces Investment Opinion on TPS, ML, KOG, GAP and PFE</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3583428</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;PicksThatMove is pleased to bring investors special situation stocks   which have a high potential for price appreciation. &lt;/li&gt;&lt;li&gt;Turbo Power Systems (TSX: TPS), $0.05, +$0.025, 100%, is trading   this morning with encouraging gains of a 100% share price increase as   the company announced that it has entered into a five-year development   and manufacturing agreement with McQuay   International. &lt;/li&gt;&lt;li&gt;Mercator Minerals Ltd. (TSX: ML), $2.79, +$0.20, 7.72%, is making   gains this morning following yesterday's announcement that it has   entered into an Arrangement   Agreement with Stingray   Copper Inc., a copper development corporation, whereby Mercator will   acquire all of the issued and outstanding shares of Stingray in   consideration for the issue of $0.25 Mercator share for each Stingray   share.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3583428>[More...]</a>]]></description>
      <pubDate>Tue, 27 Oct 2009 19:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3583428</link>
    </item>
    <item>
      <title>MichBio Expo &amp;Amp; Conference Exhibitors Profiled</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3582960</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;MichBio, the association for Michigan's bioscience industry, will host its 5th Annual Expo &amp;amp; Conference in Kalamazoo next week.  &lt;/li&gt;&lt;li&gt;Highlights of the two-day conference include:&lt;/li&gt;&lt;li&gt;MichBio High School Career Day hosted by Western Michigan University --  Tours, including Pfizer Animal Health, Stryker Instruments, Stryker     Medical, Kalexsyn, Southwest Michigan Innovation Center, Michigan High     Throughput Screening Center, Borgess Research Institute, Eurofins AvTech     Laboratories, and Genemarkers.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3582960>[More...]</a>]]></description>
      <pubDate>Tue, 27 Oct 2009 15:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ENL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TEVA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3582960</link>
    </item>
    <item>
      <title>Ligand to Acquire Metabasis for Cash and Contingent Value Rights</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3582276</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Metabasis   Therapeutics, Inc. (NASDAQ: MBRX) announced today they have entered into   a definitive merger agreement under which Ligand will acquire all of the   outstanding shares of Metabasis.&lt;/li&gt;&lt;li&gt;The CVRs will entitle   Metabasis stockholders to cash payments as frequently as every six   months as cash is received by Ligand from proceeds from the sale or   partnering of any of the Metabasis drug development programs, among   other triggering events. &lt;/li&gt;&lt;li&gt;Such forward-looking statements   include, but are not limited to, the expected timing of closing the   merger, statements about the benefits of the transaction between Ligand   and Metabasis, including future financial and operating results and   revenue potential, the expected effect of the merger on Ligand's   operating cash burn rate, the possibility of payments being made under   the CVR agreements, the combined entity's plans, objectives,   expectations and intentions and other statements that are not historical   facts.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3582276>[More...]</a>]]></description>
      <pubDate>Tue, 27 Oct 2009 11:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MBRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3582276</link>
    </item>
    <item>
      <title>Form  4          RICHO ANNA                For: Nov 05 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3615861</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3615861>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 23:55:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3615861</link>
    </item>
    <item>
      <title>Form  4          BONANNI FABRIZIO          For: Nov 05 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3615810</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3615810>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 23:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3615810</link>
    </item>
    <item>
      <title>Form  4          Metza Kristen             For: Nov 04 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3615753</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3615753>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 22:58:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3615753</link>
    </item>
    <item>
      <title>Form  4          SHARER KEVIN W            For: Nov 05 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3615510</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3615510>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 21:45:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3615510</link>
    </item>
    <item>
      <title>Form  4          Alton Gregg H             For: Nov 02 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608172</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608172>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:59:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608172</link>
    </item>
    <item>
      <title>Form  4          ABBOTT LABORATORIES       For: Nov 02  Filed by: ALBAN CARLOS (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608085</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608085>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:44:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608085</link>
    </item>
    <item>
      <title>Form  4          ABBOTT LABORATORIES       For: Nov 02  Filed by: Mason Heather L (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608077</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608077>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608077</link>
    </item>
    <item>
      <title>Form  4          GALLAGHER MICHAEL R       For: Nov 03 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608075</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608075>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:41:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608075</link>
    </item>
    <item>
      <title>Form  4          INGRAM DOUGLAS S          For: Nov 03 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608023</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608023>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:32:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608023</link>
    </item>
    <item>
      <title>Form  4          Redmond Cavan M.          For: Oct 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3604098</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3604098>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 21:58:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3604098</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=ABT,AGN,AMGN,CVTX,GILD,INCY,JNJ,PARD,PFE,RIGL,ROSG,WYE," rel="self" type="application/rss+xml" />
  </channel>
</rss>